Do not use Molnupiravur, Favipiravir, Azithromycin, Doxycycline, Ivermectin etc in COVID-19: ICMR revised guidelines

Published On 2023-03-20 11:40 GMT | Update On 2023-10-28 08:53 GMT

With a sudden spurt in COVID-19 cases across various parts of the country, the Indian Council of Medical Research (ICMR), the leading body for medical research has now issued revised guidelines for management of COVID-19

One of the major changes that are aimed to draw the attention of medical practitioners is the special DO NOT USE in COVID-19 Section that lists down various medicines including Lopinavir-ritonavir, HCQ, Ivermectin, Convalescent plasma, Molnupiravir, Favipiravir, Azithromycin, Doxycycline which are not be used for management of COVID-19

For more details, check out the link given below:

MAJOR UPDATE: Do Not Use Molnupiravur, Favipiravir, Azithromycin, Doxycycline, Ivermectin Etc In COVID-19, Says ICMR New Guideline

Full View

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Nandita Mohan

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Do not use Molnupiravur, Favipiravir, Azithromycin, Doxycycline, Ivermectin etc in COVID-19: ICMR revised guidelines

Similar News

UPSC Aspirant passes away after alleged negligence at UP CHC

SC directs NMC to issue fresh guidelines for admitting PwD candidates to MBBS courses

ICU, CCU Guidelines: Uttrakhand Director General of Health slammed by SC

SC upholds NCDRC order directing 6 Chhattisgarh-based doctors to pay compensation for deficiency in service

Ragging of 13 first-year MBBS students at Rajasthan's Medical College, 10 medicos students expelled

Rural Posting allotted 1.5 yrs after completing MBBS! High Court issues notice as Doctor challenges Rs 25 lakh bond penalty

Madras HC grants relief to MBBS aspirant who mistakenly chose BDS course during counselling

Govt invites applications to fill up top NMC vacant posts